Marketing

Rethinking your commercial activities and plans that are being affected by COVID-19? We are here to support you.

RESOURCES

Inspiring trust in the pharma industry during a global pandemic

In global trust barometers, scientists have long featured among the professions most trusted by the public, but pharmaceutical companies remain the least trusted. This is an interesting dichotomy, given that most pharmaceutical employees are scientists. Public trust has been an issue for the pharmaceutical industry for many years, driven principally by a few high-profile examples […]

View

Taking steps to ensure flu vaccinations are a priority in a pandemic

Every flu season is unpredictable. And while flu activity in the 2020–2021 season appears to be low so far, there may be a rise in influenza cases in the coming months at the same time the US is seeing an unprecedented number of COVID-19 cases. With emergency rooms and hospitals strained to capacity due to […]

View

Mental health is more than just one day

World Mental Health Awareness Day falls in October, and there is a growing flurry of activity online each year as individuals, brands and organizations share messages of compassion and support towards smashing the stigma around mental health. Current research shows that employees require more structured support when it comes to their wellbeing, particularly due to […]

View

Ensuring an open channel with regulatory and medical policy opinion leaders during COVID-19

Many companies, particularly new entrants into the U.S. pharma arena, are facing some level of disruption or impact on their projected timelines for seeking FDA licensure, gathering data from trials for filing, conducting health economics analyses needed to demonstrate improved outcomes, or conducting real-world evidence studies that can help inform medical societies’ deliberations on clinical […]

View

Assessing and managing issues around clinical trials: a multi-stakeholder approach

Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.

View

Adjusting launch planning in light of clinical trial delays

Clinical trial delays not only impact the current path forward but potentially (depending on the extent of the delay/disruption) can create hurdles for future regulatory filing, approval and launch. Therefore, as with all functions being affected by the pandemic, adaptability will be critical.

View

Unlocking virtual medical congresses

Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.

View

No two virtual congresses are the same

Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format.

Download PDF

Get in Touch

We know there are numerous considerations when it comes to the impact of COVID-19 and what this means for your organization. We are here to help.